The Impact of Pancreatic and Biliary Cancers on the ERCP Market The escalating global incidence of pancreatic and biliary cancers is a major driving force behind the growth of the Endoscopic Retrograde Cholangiopancreatography Market. ERCP is an indispensable tool in the diagnosis, staging, and management of these aggressive malignancies, making its market trajectory closely linked to cancer...